Scottsville

Researchers are studying the real-world use of the Optilume174; BPH Catheter System in men who have symptoms caused by benign prostatic hyperplasia (BPH), which is an enlarged prostate condition. This prospective registry collects information from multiple sites to better understand how this treatment works outside of controlled clinical trials. The study aims to evaluate both the effectiveness and safety of the catheter system in this patient group. The study involves collecting data from men who are undergoing treatment with the Optilume drug-coated catheter system as part of their regular care. No additional experimental treatments or randomization are described, as the focus is on observing patient outcomes with this device during usual medical practice. Participants will be monitored for changes in their urinary symptoms using the International Prostate Symptom Score (IPSS) from the start of treatment to 12 months later. Safety is also tracked by recording any serious adverse events related to the treatment during the same period. Data collection includes patient reports and clinical follow-ups over the course of one year to assess both benefit and safety outcomes.